fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
fincash number+91-22-48913909
Top 10 Equity Mutual Funds of 2024 | Performance Review

Fincash » Mutual Funds » Best Performing Equity Funds 2018

Best Equity Mutual Funds of 2024

Updated on May 13, 2025 , 700 views

Equity Funds are the ones whose accumulated fund money is invested in equity and equity-related instruments of various companies. The equity funds are considered as a long-term investment option for people having a moderate and high-risk appetite. The various categories of equity funds include Large cap funds, mid cap funds, Small cap funds, ELSS, and so on. In the year 2024, there was an upsurge witnessed in the equity markets due to which most of the equity fund categories have performed well. The performance of these funds depends on a lot of macro and microeconomic parameters such as Industry performance, company performance, the earning and profits of the companies, its future potentials, and so on. The top and Best equity funds for the year 2024 are as follows.

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Top 10 Equity Mutual Funds of 2024 Based on Performance

FundNAVNet Assets (Cr)2024 (%)2023 (%)2022 (%)2021 (%)2020 (%)
Motilal Oswal Midcap 30 Fund  Growth ₹99.4291
↑ 0.40
₹26,02857.141.710.755.89.3
LIC MF Infrastructure Fund Growth ₹47.6892
↑ 0.88
₹87447.844.47.946.6-0.1
Motilal Oswal Long Term Equity Fund Growth ₹50.6566
↑ 0.91
₹3,81747.7371.832.18.8
Motilal Oswal Multicap 35 Fund Growth ₹60.1363
↑ 0.13
₹12,26745.731-315.310.3
Invesco India Mid Cap Fund Growth ₹166.99
↑ 0.50
₹5,77943.134.10.543.124.4
UTI Healthcare Fund Growth ₹272.199
↓ -0.51
₹1,04242.938.2-12.319.167.4
SBI Healthcare Opportunities Fund Growth ₹418.188
↑ 2.40
₹3,61142.238.2-620.165.8
TATA India Pharma & Healthcare Fund Growth ₹29.5738
↓ -0.03
₹1,18440.436.6-819.164.4
IDBI Small Cap Fund Growth ₹29.2733
↑ 0.19
₹4944033.42.464.719
L&T Midcap Fund Growth ₹370.562
↑ 2.35
₹10,36239.7401.130.419
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 16 May 25

Top & Best Equity Mutual Funds of 2024

1. Motilal Oswal Midcap 30 Fund 

(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Motilal Oswal Midcap 30 Fund  is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 22.7% since its launch.  Ranked 27 in Mid Cap category.  Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% .

Below is the key information for Motilal Oswal Midcap 30 Fund 

Motilal Oswal Midcap 30 Fund 
Growth
Launch Date 24 Feb 14
NAV (16 May 25) ₹99.4291 ↑ 0.40   (0.41 %)
Net Assets (Cr) ₹26,028 on 31 Mar 25
Category Equity - Mid Cap
AMC Motilal Oswal Asset Management Co. Ltd
Rating
Risk Moderately High
Expense Ratio 0.66
Sharpe Ratio 0.47
Information Ratio 0.63
Alpha Ratio 8.9
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Apr 20₹10,000
30 Apr 21₹15,779
30 Apr 22₹22,526
30 Apr 23₹24,941
30 Apr 24₹40,218
30 Apr 25₹45,886

Motilal Oswal Midcap 30 Fund  SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹773,746.
Net Profit of ₹473,746
Invest Now

Returns for Motilal Oswal Midcap 30 Fund 

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25

DurationReturns
1 Month 10.5%
3 Month 8%
6 Month -3.2%
1 Year 19.8%
3 Year 32.4%
5 Year 38.2%
10 Year
15 Year
Since launch 22.7%
Historical performance (Yearly) on absolute basis
YearReturns
2024 57.1%
2023 41.7%
2022 10.7%
2021 55.8%
2020 9.3%
2019 9.7%
2018 -12.7%
2017 30.8%
2016 5.2%
2015 16.5%
Fund Manager information for Motilal Oswal Midcap 30 Fund 
NameSinceTenure
Ajay Khandelwal1 Oct 240.58 Yr.
Niket Shah1 Jul 204.83 Yr.
Rakesh Shetty22 Nov 222.44 Yr.
Sunil Sawant1 Jul 240.83 Yr.

Data below for Motilal Oswal Midcap 30 Fund  as on 31 Mar 25

Equity Sector Allocation
SectorValue
Technology29.99%
Consumer Cyclical16.64%
Industrials14.58%
Health Care4.76%
Communication Services3.95%
Real Estate3.03%
Basic Materials2.07%
Utility0.35%
Financial Services0.09%
Asset Allocation
Asset ClassValue
Cash32.1%
Equity67.9%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT
10%₹2,794 Cr5,250,000
↑ 750,200
Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE
9%₹2,630 Cr3,600,000
↑ 350,000
Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL
8%₹2,246 Cr43,490,250
↑ 3,495,625
Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB
5%₹1,380 Cr2,500,000
↑ 275,000
Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON
4%₹1,210 Cr735,200
Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | 500251
4%₹1,105 Cr2,135,744
Bharti Hexacom Ltd (Communication Services)
Equity, Since 31 Oct 24 | BHARTIHEXA
4%₹1,098 Cr6,500,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | MAXHEALTH
4%₹1,095 Cr9,969,361
One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 543396
4%₹1,071 Cr12,388,500
KEI Industries Ltd (Industrials)
Equity, Since 30 Nov 24 | KEI
3%₹827 Cr2,700,000
↑ 200,000

2. LIC MF Infrastructure Fund

The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector.

LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a CAGR/Annualized return of 9.4% since its launch.  Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% .

Below is the key information for LIC MF Infrastructure Fund

LIC MF Infrastructure Fund
Growth
Launch Date 29 Feb 08
NAV (16 May 25) ₹47.6892 ↑ 0.88   (1.89 %)
Net Assets (Cr) ₹874 on 31 Mar 25
Category Equity - Sectoral
AMC LIC Mutual Fund Asset Mgmt Co Ltd
Rating Not Rated
Risk High
Expense Ratio 2.3
Sharpe Ratio 0.41
Information Ratio 0.35
Alpha Ratio 15.98
Min Investment 5,000
Min SIP Investment 1,000
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Apr 20₹10,000
30 Apr 21₹14,908
30 Apr 22₹19,688
30 Apr 23₹21,272
30 Apr 24₹36,718
30 Apr 25₹38,183

LIC MF Infrastructure Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹689,048.
Net Profit of ₹389,048
Invest Now

Returns for LIC MF Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25

DurationReturns
1 Month 8.8%
3 Month 14%
6 Month -3.2%
1 Year 9%
3 Year 31.4%
5 Year 34%
10 Year
15 Year
Since launch 9.4%
Historical performance (Yearly) on absolute basis
YearReturns
2024 47.8%
2023 44.4%
2022 7.9%
2021 46.6%
2020 -0.1%
2019 13.3%
2018 -14.6%
2017 42.2%
2016 -2.2%
2015 -6.2%
Fund Manager information for LIC MF Infrastructure Fund
NameSinceTenure
Yogesh Patil18 Sep 204.62 Yr.
Mahesh Bendre1 Jul 240.83 Yr.

Data below for LIC MF Infrastructure Fund as on 31 Mar 25

Equity Sector Allocation
SectorValue
Industrials57.02%
Basic Materials9.14%
Consumer Cyclical8.07%
Utility7.19%
Financial Services6.17%
Real Estate3.11%
Technology2.31%
Communication Services2.26%
Health Care0.51%
Energy0.44%
Asset Allocation
Asset ClassValue
Cash3.8%
Equity96.2%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP
4%₹34 Cr408,127
Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 500655
3%₹30 Cr94,287
Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 500400
3%₹28 Cr724,927
Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | 500103
3%₹24 Cr1,062,199
↑ 79,197
REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 532955
3%₹24 Cr571,332
Hitachi Energy India Ltd Ordinary Shares (Industrials)
Equity, Since 31 Jul 22 | POWERINDIA
3%₹23 Cr15,928
↑ 2,851
Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS
3%₹22 Cr537,216
↑ 46,853
Hindustan Aeronautics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Oct 23 | HAL
2%₹22 Cr49,106
↑ 3,972
TD Power Systems Ltd (Industrials)
Equity, Since 30 Apr 23 | TDPOWERSYS
2%₹21 Cr476,469
GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 522275
2%₹20 Cr126,914

3. Motilal Oswal Long Term Equity Fund

(Erstwhile Motilal Oswal MOSt Focused Long Term Fund)

The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 16.8% since its launch.  Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% .

Below is the key information for Motilal Oswal Long Term Equity Fund

Motilal Oswal Long Term Equity Fund
Growth
Launch Date 21 Jan 15
NAV (16 May 25) ₹50.6566 ↑ 0.91   (1.83 %)
Net Assets (Cr) ₹3,817 on 31 Mar 25
Category Equity - ELSS
AMC Motilal Oswal Asset Management Co. Ltd
Rating Not Rated
Risk Moderately High
Expense Ratio 0.74
Sharpe Ratio 0.26
Information Ratio 0.83
Alpha Ratio 5.9
Min Investment 500
Min SIP Investment 500
Exit Load NIL

Growth of 10,000 investment over the years.

DateValue
30 Apr 20₹10,000
30 Apr 21₹14,799
30 Apr 22₹16,837
30 Apr 23₹18,446
30 Apr 24₹29,496
30 Apr 25₹31,121

Motilal Oswal Long Term Equity Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹612,552.
Net Profit of ₹312,552
Invest Now

Returns for Motilal Oswal Long Term Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25

DurationReturns
1 Month 10.2%
3 Month 13.8%
6 Month -1.3%
1 Year 13.4%
3 Year 29.3%
5 Year 28.8%
10 Year
15 Year
Since launch 16.8%
Historical performance (Yearly) on absolute basis
YearReturns
2024 47.7%
2023 37%
2022 1.8%
2021 32.1%
2020 8.8%
2019 13.2%
2018 -8.7%
2017 44%
2016 12.5%
2015
Fund Manager information for Motilal Oswal Long Term Equity Fund
NameSinceTenure
Ajay Khandelwal11 Dec 231.39 Yr.
Rakesh Shetty22 Nov 222.44 Yr.
Atul Mehra1 Oct 240.58 Yr.

Data below for Motilal Oswal Long Term Equity Fund as on 31 Mar 25

Equity Sector Allocation
SectorValue
Industrials34.02%
Consumer Cyclical21.13%
Financial Services17.41%
Technology9.22%
Real Estate7.02%
Basic Materials6.25%
Health Care2.8%
Asset Allocation
Asset ClassValue
Cash2.14%
Equity97.86%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 543320
6%₹231 Cr9,923,692
Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | 500251
6%₹220 Cr425,260
Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES
4%₹171 Cr297,751
Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials)
Equity, Since 28 Feb 23 | FLUOROCHEM
4%₹163 Cr417,990
↑ 9,104
Bharat Dynamics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Dec 23 | BDL
4%₹162 Cr1,056,315
↑ 63,547
Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER
4%₹148 Cr240,350
↑ 5,306
Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE
4%₹145 Cr1,055,205
Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 29 Feb 24 | MCX
4%₹144 Cr235,083
Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | KALYANKJIL
4%₹139 Cr2,700,149
Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | SUZLON
4%₹139 Cr24,702,337
↑ 633,524

4. Motilal Oswal Multicap 35 Fund

(Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 17.6% since its launch.  Ranked 5 in Multi Cap category.  Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% .

Below is the key information for Motilal Oswal Multicap 35 Fund

Motilal Oswal Multicap 35 Fund
Growth
Launch Date 28 Apr 14
NAV (16 May 25) ₹60.1363 ↑ 0.13   (0.22 %)
Net Assets (Cr) ₹12,267 on 31 Mar 25
Category Equity - Multi Cap
AMC Motilal Oswal Asset Management Co. Ltd
Rating
Risk Moderately High
Expense Ratio 0.94
Sharpe Ratio 0.56
Information Ratio 0.79
Alpha Ratio 11.84
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Apr 20₹10,000
30 Apr 21₹14,099
30 Apr 22₹14,698
30 Apr 23₹14,918
30 Apr 24₹22,918
30 Apr 25₹26,106

Motilal Oswal Multicap 35 Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹556,833.
Net Profit of ₹256,833
Invest Now

Returns for Motilal Oswal Multicap 35 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25

DurationReturns
1 Month 8.5%
3 Month 9.5%
6 Month 2.5%
1 Year 19.1%
3 Year 26.4%
5 Year 24.2%
10 Year
15 Year
Since launch 17.6%
Historical performance (Yearly) on absolute basis
YearReturns
2024 45.7%
2023 31%
2022 -3%
2021 15.3%
2020 10.3%
2019 7.9%
2018 -7.8%
2017 43.1%
2016 8.5%
2015 14.6%
Fund Manager information for Motilal Oswal Multicap 35 Fund
NameSinceTenure
Ajay Khandelwal1 Oct 240.58 Yr.
Niket Shah1 Jul 222.83 Yr.
Rakesh Shetty22 Nov 222.44 Yr.
Atul Mehra1 Oct 240.58 Yr.
Sunil Sawant1 Jul 240.83 Yr.

Data below for Motilal Oswal Multicap 35 Fund as on 31 Mar 25

Equity Sector Allocation
SectorValue
Technology22.21%
Industrials17.67%
Consumer Cyclical13.37%
Financial Services8.49%
Communication Services5.69%
Consumer Defensive3.15%
Health Care1.77%
Asset Allocation
Asset ClassValue
Cash28.32%
Equity71.68%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE
10%₹1,260 Cr1,725,000
↑ 228,975
Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT
9%₹1,171 Cr2,200,000
↑ 207,900
Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB
9%₹1,104 Cr1,999,875
↑ 5,800
Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL
7%₹924 Cr17,885,620
↑ 380,009
CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | 500093
6%₹757 Cr12,074,170
↑ 416,875
Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | 500251
6%₹722 Cr1,394,889
↓ -5,611
Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 890157
6%₹707 Cr4,999,500
↓ -500
Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN
5%₹671 Cr4,500,000
Varun Beverages Ltd (Consumer Defensive)
Equity, Since 31 Mar 25 | VBL
3%₹392 Cr7,500,000
↓ -1,332,625
ICICI Bank Ltd (Financial Services)
Equity, Since 28 Feb 21 | ICICIBANK
3%₹357 Cr2,499,500
↓ -500

5. Invesco India Mid Cap Fund

The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved.

Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 16.8% since its launch.  Ranked 38 in Mid Cap category.  Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% .

Below is the key information for Invesco India Mid Cap Fund

Invesco India Mid Cap Fund
Growth
Launch Date 19 Apr 07
NAV (16 May 25) ₹166.99 ↑ 0.50   (0.30 %)
Net Assets (Cr) ₹5,779 on 31 Mar 25
Category Equity - Mid Cap
AMC Invesco Asset Management (India) Private Ltd
Rating
Risk Moderately High
Expense Ratio 1.89
Sharpe Ratio 0.56
Information Ratio 0
Alpha Ratio 0
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Apr 20₹10,000
30 Apr 21₹15,625
30 Apr 22₹19,175
30 Apr 23₹20,440
30 Apr 24₹30,748
30 Apr 25₹35,711

Invesco India Mid Cap Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹657,502.
Net Profit of ₹357,502
Invest Now

Returns for Invesco India Mid Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25

DurationReturns
1 Month 8.9%
3 Month 14.4%
6 Month 4.4%
1 Year 21.8%
3 Year 29.8%
5 Year 31.3%
10 Year
15 Year
Since launch 16.8%
Historical performance (Yearly) on absolute basis
YearReturns
2024 43.1%
2023 34.1%
2022 0.5%
2021 43.1%
2020 24.4%
2019 3.8%
2018 -5.3%
2017 44.3%
2016 1.1%
2015 6.4%
Fund Manager information for Invesco India Mid Cap Fund
NameSinceTenure
Aditya Khemani9 Nov 231.47 Yr.
Amit Ganatra1 Sep 231.66 Yr.

Data below for Invesco India Mid Cap Fund as on 31 Mar 25

Equity Sector Allocation
SectorValue
Financial Services24.93%
Health Care19.78%
Consumer Cyclical16.18%
Industrials11.5%
Basic Materials9.42%
Technology9.31%
Real Estate6.89%
Communication Services1.79%
Asset Allocation
Asset ClassValue
Cash0.2%
Equity99.8%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE
5%₹278 Cr506,411
↑ 69,877
L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF
4%₹258 Cr16,854,973
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH
4%₹246 Cr2,246,434
The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK
4%₹241 Cr12,506,782
Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | 500251
4%₹224 Cr421,151
↑ 34,656
JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT
4%₹213 Cr431,234
Dixon Technologies (India) Ltd (Technology)
Equity, Since 28 Feb 22 | DIXON
4%₹205 Cr155,335
Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE
3%₹196 Cr1,657,183
↑ 95,829
Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | 500271
3%₹193 Cr1,684,103
Coforge Ltd (Technology)
Equity, Since 31 Mar 22 | COFORGE
3%₹190 Cr234,918

6. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a CAGR/Annualized return of 14.9% since its launch.  Ranked 40 in Sectoral category.  Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% .

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund
Growth
Launch Date 28 Jun 99
NAV (16 May 25) ₹272.199 ↓ -0.51   (-0.19 %)
Net Assets (Cr) ₹1,042 on 31 Mar 25
Category Equity - Sectoral
AMC UTI Asset Management Company Ltd
Rating
Risk High
Expense Ratio 2.38
Sharpe Ratio 0.66
Information Ratio -0.23
Alpha Ratio 1.04
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Apr 20₹10,000
30 Apr 21₹15,214
30 Apr 22₹15,571
30 Apr 23₹15,015
30 Apr 24₹22,423
30 Apr 25₹27,036

UTI Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹530,691.
Net Profit of ₹230,691
Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25

DurationReturns
1 Month 2.7%
3 Month 6.2%
6 Month -2.2%
1 Year 21.5%
3 Year 23.6%
5 Year 22.5%
10 Year
15 Year
Since launch 14.9%
Historical performance (Yearly) on absolute basis
YearReturns
2024 42.9%
2023 38.2%
2022 -12.3%
2021 19.1%
2020 67.4%
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%
Fund Manager information for UTI Healthcare Fund
NameSinceTenure
Kamal Gada2 May 223 Yr.

Data below for UTI Healthcare Fund as on 31 Mar 25

Equity Sector Allocation
SectorValue
Health Care97.95%
Basic Materials0.97%
Asset Allocation
Asset ClassValue
Cash1.08%
Equity98.92%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
12%₹123 Cr672,889
↓ -27,111
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
6%₹62 Cr400,000
↓ -20,000
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY
5%₹47 Cr396,000
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331
5%₹47 Cr172,829
↓ -2,056
Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL
4%₹41 Cr79,763
↑ 5,763
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP
4%₹39 Cr56,271
Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 532296
4%₹38 Cr275,250
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
3%₹34 Cr56,000
Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM
3%₹33 Cr63,840
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 532843
3%₹32 Cr465,000

7. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a CAGR/Annualized return of 15.5% since its launch.  Ranked 34 in Sectoral category.  Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% .

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund
Growth
Launch Date 31 Dec 04
NAV (15 May 25) ₹418.188 ↑ 2.40   (0.58 %)
Net Assets (Cr) ₹3,611 on 31 Mar 25
Category Equity - Sectoral
AMC SBI Funds Management Private Limited
Rating
Risk High
Expense Ratio 2.09
Sharpe Ratio 0.77
Information Ratio 0.67
Alpha Ratio 2.51
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Apr 20₹10,000
30 Apr 21₹15,282
30 Apr 22₹15,865
30 Apr 23₹16,168
30 Apr 24₹24,854
30 Apr 25₹30,132

SBI Healthcare Opportunities Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹556,833.
Net Profit of ₹256,833
Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25

DurationReturns
1 Month 2.2%
3 Month 5.7%
6 Month 1.2%
1 Year 20.7%
3 Year 27.4%
5 Year 24.9%
10 Year
15 Year
Since launch 15.5%
Historical performance (Yearly) on absolute basis
YearReturns
2024 42.2%
2023 38.2%
2022 -6%
2021 20.1%
2020 65.8%
2019 -0.5%
2018 -9.9%
2017 2.1%
2016 -14%
2015 27.1%
Fund Manager information for SBI Healthcare Opportunities Fund
NameSinceTenure
Tanmaya Desai1 Jun 1113.92 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 Mar 25

Equity Sector Allocation
SectorValue
Health Care91.24%
Basic Materials6.15%
Asset Allocation
Asset ClassValue
Cash2.6%
Equity97.4%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA
14%₹513 Cr2,800,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
7%₹243 Cr400,000
↑ 25,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH
6%₹231 Cr2,100,000
↓ -100,000
Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 500087
5%₹186 Cr1,200,000
Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3A
5%₹182 Cr300,000
Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 500257
5%₹176 Cr840,000
Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED
4%₹139 Cr540,000
Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND
4%₹138 Cr560,000
Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 543308
4%₹134 Cr2,034,372
↓ -65,628
Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL
3%₹117 Cr800,000

8. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a CAGR/Annualized return of 12.3% since its launch.  Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% .

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund
Growth
Launch Date 28 Dec 15
NAV (16 May 25) ₹29.5738 ↓ -0.03   (-0.12 %)
Net Assets (Cr) ₹1,184 on 31 Mar 25
Category Equity - Sectoral
AMC Tata Asset Management Limited
Rating Not Rated
Risk High
Expense Ratio 0
Sharpe Ratio 0.42
Information Ratio 0.57
Alpha Ratio 2.09
Min Investment 5,000
Min SIP Investment 150
Exit Load 0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Apr 20₹10,000
30 Apr 21₹14,766
30 Apr 22₹15,521
30 Apr 23₹15,212
30 Apr 24₹23,213
30 Apr 25₹27,062

TATA India Pharma & Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹530,691.
Net Profit of ₹230,691
Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25

DurationReturns
1 Month 3.3%
3 Month 6.2%
6 Month 0.6%
1 Year 17.4%
3 Year 23.7%
5 Year 22.5%
10 Year
15 Year
Since launch 12.3%
Historical performance (Yearly) on absolute basis
YearReturns
2024 40.4%
2023 36.6%
2022 -8%
2021 19.1%
2020 64.4%
2019 5.5%
2018 -2.6%
2017 4.7%
2016 -14.7%
2015
Fund Manager information for TATA India Pharma & Healthcare Fund
NameSinceTenure
Meeta Shetty9 Mar 214.15 Yr.
Rajat Srivastava16 Sep 240.62 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 31 Mar 25

Equity Sector Allocation
SectorValue
Health Care91.11%
Basic Materials2.29%
Asset Allocation
Asset ClassValue
Cash6.59%
Equity93.41%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA
13%₹157 Cr854,300
↑ 50,000
Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 500087
6%₹76 Cr490,000
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA
6%₹76 Cr615,100
↓ -125,900
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP
6%₹71 Cr101,255
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
5%₹64 Cr104,965
Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 500257
5%₹64 Cr303,240
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 532843
5%₹59 Cr855,100
Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM
4%₹48 Cr956,991
Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM
3%₹38 Cr75,249
HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCG
3%₹37 Cr666,121

9. IDBI Small Cap Fund

The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However there can be no assurance that the investment objective under the Scheme will be realized.

IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 14.5% since its launch.  Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% .

Below is the key information for IDBI Small Cap Fund

IDBI Small Cap Fund
Growth
Launch Date 21 Jun 17
NAV (16 May 25) ₹29.2733 ↑ 0.19   (0.64 %)
Net Assets (Cr) ₹494 on 31 Mar 25
Category Equity - Small Cap
AMC IDBI Asset Management Limited
Rating Not Rated
Risk Moderately High
Expense Ratio 2.3
Sharpe Ratio 0.29
Information Ratio -0.19
Alpha Ratio 5.7
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Apr 20₹10,000
30 Apr 21₹18,100
30 Apr 22₹24,313
30 Apr 23₹25,270
30 Apr 24₹37,716
30 Apr 25₹38,352

IDBI Small Cap Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹689,048.
Net Profit of ₹389,048
Invest Now

Returns for IDBI Small Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25

DurationReturns
1 Month 2.8%
3 Month 7%
6 Month -7.4%
1 Year 6.3%
3 Year 22.7%
5 Year 33.4%
10 Year
15 Year
Since launch 14.5%
Historical performance (Yearly) on absolute basis
YearReturns
2024 40%
2023 33.4%
2022 2.4%
2021 64.7%
2020 19%
2019 -4.4%
2018 -15%
2017
2016
2015
Fund Manager information for IDBI Small Cap Fund
NameSinceTenure
Nikhil Rungta1 Jul 240.83 Yr.
Mahesh Bendre1 Jul 240.83 Yr.

Data below for IDBI Small Cap Fund as on 31 Mar 25

Equity Sector Allocation
SectorValue
Industrials34.47%
Consumer Cyclical18.99%
Basic Materials9.6%
Consumer Defensive8.03%
Utility6.81%
Financial Services5.3%
Health Care4.9%
Technology4.1%
Communication Services3.36%
Real Estate0.41%
Energy0.01%
Asset Allocation
Asset ClassValue
Cash4%
Equity96%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sanathan Textiles Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | SANATHAN
3%₹17 Cr401,251
JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 534600
3%₹16 Cr2,506,932
↑ 480,066
Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO
3%₹16 Cr711,662
↓ -40,456
Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 541974
3%₹15 Cr115,327
↑ 8,520
TD Power Systems Ltd (Industrials)
Equity, Since 31 Aug 23 | TDPOWERSYS
3%₹14 Cr327,391
↑ 11,229
Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER
3%₹14 Cr270,441
Hindustan Foods Ltd (Industrials)
Equity, Since 31 Jul 24 | 519126
2%₹12 Cr220,054
↑ 74,304
International Gemmological Institute (India) Ltd (Basic Materials)
Equity, Since 31 Dec 24 | IGIL
2%₹12 Cr337,832
Praveg Ltd Ordinary Shares (Communication Services)
Equity, Since 31 Dec 24 | 531637
2%₹12 Cr212,056
↑ 16,354
Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | NAVKARCORP
2%₹11 Cr1,084,277

10. L&T Midcap Fund

To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100.

L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a CAGR/Annualized return of 19% since its launch.  Ranked 5 in Mid Cap category.  Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% .

Below is the key information for L&T Midcap Fund

L&T Midcap Fund
Growth
Launch Date 9 Aug 04
NAV (16 May 25) ₹370.562 ↑ 2.35   (0.64 %)
Net Assets (Cr) ₹10,362 on 31 Mar 25
Category Equity - Mid Cap
AMC L&T Investment Management Ltd
Rating
Risk High
Expense Ratio 1.77
Sharpe Ratio 0.15
Information Ratio -0.28
Alpha Ratio 0.31
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Apr 20₹10,000
30 Apr 21₹15,852
30 Apr 22₹18,154
30 Apr 23₹18,640
30 Apr 24₹29,994
30 Apr 25₹31,358

L&T Midcap Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹598,181.
Net Profit of ₹298,181
Invest Now

Returns for L&T Midcap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25

DurationReturns
1 Month 9.5%
3 Month 14%
6 Month -1.6%
1 Year 9.7%
3 Year 26.2%
5 Year 27.9%
10 Year
15 Year
Since launch 19%
Historical performance (Yearly) on absolute basis
YearReturns
2024 39.7%
2023 40%
2022 1.1%
2021 30.4%
2020 19%
2019 -0.2%
2018 -12%
2017 52.3%
2016 9.8%
2015 10.8%
Fund Manager information for L&T Midcap Fund
NameSinceTenure
Venugopal Manghat1 Oct 231.58 Yr.
Cheenu Gupta26 Nov 222.43 Yr.
Sonal Gupta1 Oct 231.58 Yr.

Data below for L&T Midcap Fund as on 31 Mar 25

Equity Sector Allocation
SectorValue
Industrials24.25%
Consumer Cyclical18.67%
Financial Services16.23%
Technology14.96%
Health Care13.26%
Consumer Defensive3.76%
Utility2.42%
Basic Materials1.92%
Communication Services1.67%
Real Estate1.56%
Asset Allocation
Asset ClassValue
Cash1.3%
Equity98.7%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Sep 21 | MAXHEALTH
5%₹478 Cr4,355,000
↑ 246,080
Persistent Systems Ltd (Technology)
Equity, Since 30 Nov 22 | PERSISTENT
4%₹456 Cr827,298
BSE Ltd (Financial Services)
Equity, Since 30 Apr 24 | BSE
4%₹439 Cr800,300
Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Apr 24 | DIXON
4%₹402 Cr304,800
Indian Hotels Co Ltd (Consumer Cyclical)
Equity, Since 30 Apr 18 | 500850
4%₹377 Cr4,782,177
Trent Ltd (Consumer Cyclical)
Equity, Since 30 Jun 19 | 500251
4%₹363 Cr681,700
The Federal Bank Ltd (Financial Services)
Equity, Since 31 Jan 22 | FEDERALBNK
3%₹362 Cr18,801,000
Coforge Ltd (Technology)
Equity, Since 31 Jul 24 | COFORGE
3%₹357 Cr439,900
Lupin Ltd (Healthcare)
Equity, Since 31 Dec 22 | 500257
3%₹356 Cr1,757,400
↑ 125,300
Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Mar 24 | 543320
3%₹355 Cr17,596,500

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
How helpful was this page ?
POST A COMMENT